---
schema_version: "secwatch.filing_event.v1"
accession: "0001606498-23-000013"
form_type: "8-K"
ticker: "AVNS"
cik: "0001606498"
company_name: "AVANOS MEDICAL, INC."
filed_at: "2023-02-17T23:59:59+00:00"
generated_at: "2026-06-19T08:02:23.590524+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Avanos Medical amends CEO severance to 2.5x pay; SVP International resigns

## Summary
- CEO severance payout multiple increased from 2x to 2.5x on qualified termination.
- Arjun R. Sarker, SVP International, resigns effective May 10, 2023.
- Changes approved by Compensation Committee on Feb 14, 2023.

## SEC filing metadata
- accession: 0001606498-23-000013
- form_type: 8-K
- ticker: AVNS
- cik: 0001606498
- company_name: AVANOS MEDICAL, INC.
- filed_at: 2023-02-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1606498/000160649823000013/0001606498-23-000013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1606498/000160649823000013/avns-20230214.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001606498-23-000013
- JSON: https://secwatch.observer/filing/0001606498-23-000013.json
- Plain text: https://secwatch.observer/filing/0001606498-23-000013.txt

## Key facts
- Executive change
  Arjun R. Sarker resigned as Senior Vice President – International at AVANOS MEDICAL, INC..
  - Action: resigned
  - Role: Senior Vice President – International
  source text: On February 14, 2023, Arjun R. Sarker, the Company’s Senior Vice President – International, notified the Company that he will resign from his position with the Company, effective May 10, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1606498/000160649823000013/0001606498-23-000013-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.